Tofani A, Sciuto R, Semprebene A, Festa A, Pasqualoni R, Giunta S, Mottolese M, Benevolo M, Botti C, Maini C L
Department of Nuclear Medicine, Regina Elená National Cancer Institute, Rome, Italy.
Nucl Med Commun. 1999 Dec;20(12):1113-21. doi: 10.1097/00006231-199912000-00003.
We evaluated the diagnostic yield of 99Tcm-MIBI scintimammography in a relatively large series of consecutive patients referred for breast surgery on the basis of physical examination or mammogram. 99Tcm-MIBI uptake was correlated to tumour size, receptor status, neovascularity, proliferating activity, P-170 glycoprotein expression and the patient's gonadal state. Three hundred consecutive patients referred to our institution, with either a positive mammogram or a palpable mass, were entered into the study. All patients underwent 99Tcm-MIBI scintimammography. Pathological status was obtained after surgery in all patients. Breast cancer was diagnosed in 218 (73%) patients. The MIBI scan was positive in 89% (194/218) cancer patients and in 17% (14/82) of patients with benign masses (false-positives); the scan was negative in 24 (11%) cancer patients (false-negatives). The sensitivity of MIBI scintigraphy was higher for tumours > 1 cm (95 vs 48% in lesions < or = 1 cm) and in pre-menopausal women (95 vs 85%). Conversely, the specificity was better for lesions < 1 cm (100%) and in post-menopausal women (89%). The positive predictive value of MIBI scan was good both in small (< 1 cm) and large tumours (100% and 93%, respectively) and slightly modified by gonadal state (89% and 96% in pre- and post-menopausal state). The negative predictive value was unsatisfactory, especially in small tumours and in older patients. The diagnostic performance increased stratifying data for tumour size, indicating that lesion size is a major determinant in the diagnostic accuracy of MIBI scintimammography. We conclude that 99Tcm-MIBI scintimammography is useful in the diagnostic evaluation of young patients, because it can select patients for further invasive diagnostic procedures. In older patients, a positive 99Tcm-MIBI scan is highly suggestive of malignancy and might be an indication for surgery. In the case of a negative scan, biopsy is advisable given the poor negative predictive value. Small tumour size and a well-differentiated histotype characterize false-negative cases.
我们在一系列相对大量连续的、因体格检查或乳房X线摄影而转诊至乳腺外科的患者中评估了99锝-甲氧基异丁基异腈乳腺闪烁显像的诊断效能。99锝-甲氧基异丁基异腈摄取与肿瘤大小、受体状态、新生血管形成、增殖活性、P-170糖蛋白表达及患者的性腺状态相关。300例因乳房X线摄影阳性或可触及肿块而转诊至我院的连续患者纳入本研究。所有患者均接受了99锝-甲氧基异丁基异腈乳腺闪烁显像。所有患者术后均获得病理状态。218例(73%)患者被诊断为乳腺癌。MIBI扫描在89%(194/218)的癌症患者中呈阳性,在17%(14/82)的良性肿块患者中呈阳性(假阳性);扫描在24例(11%)癌症患者中呈阴性(假阴性)。MIBI闪烁显像对直径>1 cm的肿瘤敏感性更高(直径≤1 cm的病变为95%对48%),在绝经前女性中敏感性更高(95%对85%)。相反,对于直径<1 cm的病变(100%)和绝经后女性(89%),特异性更好。MIBI扫描的阳性预测值在小(<1 cm)大肿瘤中均良好(分别为100%和93%),并受性腺状态轻微影响(绝经前和绝经后状态分别为89%和96%)。阴性预测值不令人满意,尤其是在小肿瘤和老年患者中。根据肿瘤大小分层数据后诊断效能提高,表明病变大小是99锝-甲氧基异丁基异腈乳腺闪烁显像诊断准确性的主要决定因素。我们得出结论,99锝-甲氧基异丁基异腈乳腺闪烁显像在年轻患者的诊断评估中有用,因为它可以筛选出需要进一步进行侵入性诊断程序的患者。在老年患者中,99锝-甲氧基异丁基异腈扫描阳性高度提示恶性肿瘤,可能是手术指征。在扫描阴性的情况下,鉴于阴性预测值较差,建议进行活检。假阴性病例的特征是肿瘤小且组织学类型分化良好。